Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis

OBJECTIVE: Recent studies have raised concern about the cardiovascular safety of dipeptidyl peptidase-4 (DPP4) inhibitors. We performed a systematic review through meta-analysis to compare cardiovascular outcomes of sulfonylurea (SU) versus DPP4 inhibitors when used in combination with metformin. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Won Kyeong, Kang, Jeehoon, Kim, Hyo-Soo, Park, Kyung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159755/
https://www.ncbi.nlm.nih.gov/pubmed/34095013
http://dx.doi.org/10.12997/jla.2021.10.2.210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159755/
https://www.ncbi.nlm.nih.gov/pubmed/34095013
http://dx.doi.org/10.12997/jla.2021.10.2.210

Ejemplares similares